NBIX

BUY

Neurocrine Biosciences, Inc.· Healthcare

Market Cap: $14.4B

Score
73
73

ANDAMENTO PREZZO

$141.31+22.12%

Prezzi aggiornati al 21 ott 2026

INDICATORI TECNICI

RSI (14 giorni)

51Neutro
▪ <30 Ipervenduto (segnale buy)
▪ 30–45 Zona debolezza
▪ 45–55 Neutro
▪ >70 Ipercomprato (attenzione)

MACD (12,26,9)

↑ RialzistaMACD -2.793 · Signal -3.395 · Hist 0.602

Prezzo vs Medie Mobili

SMA 20
$140.21-20.2%
SMA 50
$147.86-24.3%
SMA 200
$147.05-23.9%
Bollinger Band %B0% — Vicino lower band
$134mid $140$146
Volume ratio (vs media 20gg)0.60x

BREAKDOWN SCORE (0 → 100)

P/E Trailing17.9 / 25
FCF Yield21.7 / 25
Price/Book13.1 / 15
EPS10.2 / 15
Debt/Equity10.0 / 10
Dividendo0.0 / 5
Momentum 90gg0.0 / 5

FONDAMENTALI

Clicca i per spiegazione✓ 5 ok~ attenzione✗ 0 negativi
~P/E Trailing
20.7x
✓P/E Forward
11.8x
~P/B
3.9x
✓FCF Yield
5.2%
✓EPS TTM
6,82
EPS Q1
—
EPS Growth YoY
—
✓Rev. Growth
39.5%
✓Debt/Equity
0.1x
Market Cap
$14.4B
Div. Yield
0.0%
Beta
—
52w High
—
52w Low
—
DCF Value
—
Sector
Healthcare

Aggiornato: 22 ott 2026